Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments
Mediterr J Hematol Infect Dis
.
2024 Mar 1;16(1):e2024022.
doi: 10.4084/MJHID.2024.022.
eCollection 2024.
Authors
Nicola Sgherza
1
,
Anna Mestice
1
,
Angela Maria Vittoria Larocca
2
,
Pellegrino Musto
1
3
Affiliations
1
Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.
2
Hygiene Unit, AOUC Policlinico, Bari, Italy.
3
Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.
PMID:
38468827
PMCID:
PMC10927213
DOI:
10.4084/MJHID.2024.022
No abstract available
Keywords:
Breakthrough SARS-CoV-2 infection; Multiple myeloma; Serological response.